ALGS
Price
$8.21
Change
-$0.05 (-0.61%)
Updated
Jan 16, 11:03 AM (EDT)
Capitalization
50.83M
Intraday BUY SELL Signals
ANVS
Price
$3.05
Change
-$0.15 (-4.69%)
Updated
Jan 16, 11:09 AM (EDT)
Capitalization
84.81M
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs ANVS

Header iconALGS vs ANVS Comparison
Open Charts ALGS vs ANVSBanner chart's image
Aligos Therapeutics
Price$8.21
Change-$0.05 (-0.61%)
Volume$100
Capitalization50.83M
Annovis Bio
Price$3.05
Change-$0.15 (-4.69%)
Volume$1.8K
Capitalization84.81M
ALGS vs ANVS Comparison Chart in %
ALGS
Daily Signal:
Gain/Loss:
ANVS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALGS vs. ANVS commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and ANVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (ALGS: $8.26 vs. ANVS: $3.20)
Brand notoriety: ALGS and ANVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 117% vs. ANVS: 17%
Market capitalization -- ALGS: $50.83M vs. ANVS: $84.81M
ALGS [@Biotechnology] is valued at $50.83M. ANVS’s [@Biotechnology] market capitalization is $84.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileANVS’s FA Score has 0 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • ANVS’s FA Score: 0 green, 5 red.
According to our system of comparison, ANVS is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 2 TA indicator(s) are bullish while ANVS’s TA Score has 3 bullish TA indicator(s).

  • ALGS’s TA Score: 2 bullish, 8 bearish.
  • ANVS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than ALGS.

Price Growth

ALGS (@Biotechnology) experienced а -20.04% price change this week, while ANVS (@Biotechnology) price change was -18.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +41.99%.

Reported Earning Dates

ANVS is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANVS($84.8M) has a higher market cap than ALGS($50.8M). ANVS YTD gains are higher at: -7.514 vs. ALGS (-11.373). ANVS has higher annual earnings (EBITDA): -26.72M vs. ALGS (-84.01M). ALGS has more cash in the bank: 99.1M vs. ANVS (15.3M). ALGS has higher revenues than ANVS: ALGS (2.65M) vs ANVS (0).
ALGSANVSALGS / ANVS
Capitalization50.8M84.8M60%
EBITDA-84.01M-26.72M314%
Gain YTD-11.373-7.514151%
P/E RatioN/AN/A-
Revenue2.65M0-
Total Cash99.1M15.3M648%
Total Debt6.07MN/A-
FUNDAMENTALS RATINGS
ANVS: Fundamental Ratings
ANVS
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSANVS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signal:
Gain/Loss:
ANVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PREIF0.190.01
+2.95%
Precipitate Gold Corp
AEOJF8.57N/A
N/A
Aeon Financial Services Co., Ltd.
COGZF1.60N/A
N/A
Cogstate Ltd.
JCYCF23.25N/A
N/A
Jardine Cycle & Carriage Limited
CSTUF12.49N/A
N/A
Constellation Acquisition Corp I

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with RGNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-8.73%
RGNX - ALGS
48%
Loosely correlated
-7.96%
ARWR - ALGS
47%
Loosely correlated
+0.52%
DNLI - ALGS
46%
Loosely correlated
+2.79%
SYRE - ALGS
45%
Loosely correlated
-0.21%
XNCR - ALGS
45%
Loosely correlated
-8.58%
More

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+0.95%
ADXN - ANVS
43%
Loosely correlated
-1.34%
ALGS - ANVS
39%
Loosely correlated
-8.73%
MDGL - ANVS
36%
Loosely correlated
-1.85%
VYGR - ANVS
36%
Loosely correlated
-7.51%
RGNX - ANVS
36%
Loosely correlated
-7.96%
More